Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who have received prior cisplatin-based therapy

被引：0
|
作者：
Shinohara, N
Suzuki, S
Abe, T
Sazawa, A
Harabayashi, T
Nonomura, K
机构：
来源：
JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)35464-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1319
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [41] Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies
    Masatomo Nishikawa
    Hideaki Miyake
    Masato Fujisawa
    International Journal of Clinical Oncology, 2016, 21 : 162 - 167
  • [42] THE EFFICIENCY OF SECOND-LINE CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL FOR ADVANCED UROTHELIAL CARCINOMA RESISTANT TO CISPLATIN-BASED CHEMOTHERAPY
    Nishihara, Chikako
    Kuratsukuri, Katsuyuki
    Iguchi, Taro
    Tamada, Satoshi
    Tanaka, Tomoaki
    Uchida, Junji
    Kawashima, Hidenori
    Nakatani, Tatsuya
    JOURNAL OF UROLOGY, 2013, 189 (04): : E765 - E765
  • [43] IRINOTECAN AND NEDAPLATIN AS SALVAGE THERAPY FOR PATIENTS WITH ADVANCED GERM CELL TUMOR FOLLOWING INTENSIVE TREATMENT WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPIES
    Nishikawa, Masatomo
    Miyake, Hideaki
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1060 - E1060
  • [44] Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies
    Nishikawa, Masatomo
    Miyake, Hideaki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 162 - 167
  • [45] Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy
    Koguchi, Dai
    Matsumoto, Kazumasa
    Ikeda, Masaomi
    Shimizu, Yuriko
    Nakamura, Marie
    Shiono, Yutaka
    Katsumata, Hiroki
    Sato, Yuichi
    Iwamura, Masatsugu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [46] Quality of life in patients with cisplatin-resistant urothelial cancer: Typical ailments and effect of paclitaxel-based salvage therapy
    Niegisch, Guenter
    Retz, Margitta
    Siener, Roswitha
    Albers, Peter
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 256.e15 - 256.e21
  • [47] Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy
    Ikeda, M.
    Matsumoto, K.
    Tabata, K.
    Minamida, S.
    Fujita, T.
    Satoh, T.
    Iwamura, M.
    Baba, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E864 - U820
  • [48] Combination of Gemcitabine and Paclitaxel is a Favorable Option for Patients with Advanced or Metastatic Urothelial Carcinoma Previously Treated with Cisplatin-based Chemotherapy
    Ikeda, Masaomi
    Matsumoto, Kazumasa
    Tabata, Ken-ichi
    Minamida, Satoru
    Fujita, Tetsuo
    Satoh, Takefumi
    Iwamura, Masatsugu
    Baba, Shiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (10) : 1214 - 1220
  • [49] UROTHELIAL CANCER Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum
    Raman, Jay D.
    NATURE REVIEWS UROLOGY, 2018, 15 (03) : 139 - +
  • [50] Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy
    Türkölmez, K
    Bedük, Y
    Baltaci, S
    Gögüs, Ç
    Gögüs, O
    EUROPEAN UROLOGY, 2003, 44 (06) : 682 - 686
12345